戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rticipants were taken before the walk in the hospital laboratory.
2  2, which are potentially exploitable by any hospital laboratory.
3 f gram-negative organisms encountered in the hospital laboratory.
4 and with other HPLC assays currently used in hospital laboratories.
5 or HIV according to standard practice in the hospital laboratories.
6 logy laboratory and, in some cases, at local hospital laboratories.
7 tients and 12 environmental isolates from 24 hospital laboratories across the United Kingdom on an Il
8 overed in cultures obtained at six different hospital laboratories across the United States.
9 rove the diagnostic accuracy and capacity of hospital laboratories, allowing for timely and appropria
10 e laboratory were compared with those of the hospital laboratories and risk of transfusion-associated
11 re cultured from patient infections in 71 US hospital laboratories and were submitted to a central re
12 rveillance in Baltimore and Atlanta and from hospital-laboratory-based sentinel surveillance of 12 ho
13 g a tightly clustered set of isolates from 3 hospital laboratories consistent with an outbreak from a
14  and body mass index were collected from the hospital laboratory database.
15 g conducted in 11 of the participating ICARE hospital laboratories failed to pinpoint the factors res
16                      They were referred to a hospital laboratory for an urinalysis, complete blood co
17 specimens collected from children at 11 U.S. hospital laboratories from November 1997 to March 1998 a
18                     Data were produced by 25 hospital laboratories in France.
19 rent control measures; isolates from 7 other hospital laboratories in London and southeast England we
20 . soudanense that were processed in a single hospital laboratory in Baltimore, Maryland, between 1 Ja
21                      There are concerns that hospital laboratories may have inadequate surge capaciti
22 heid, Sunnyvale, CA) performed at a district hospital laboratory or (2) POC Xpert MTB/RIF test perfor
23 r commercial HMO enrollees for professional, hospital, laboratory, pharmaceutical, and ancillary serv
24 dy investigators, paediatricians in referral hospitals, laboratory staff, and committee members were
25 due to rotavirus disease was estimated using hospital laboratory surveillance data.
26 consider the diagnosis on presentation, U.S. hospital laboratory technologists have very limited expe
27 emographics, physiologic variables, standard hospital laboratory tests, and circulating cytokine conc
28 gration of demographics, bedside physiology, hospital laboratory tests, and circulating cytokines pre
29 erial input, including patient demographics, hospital laboratory tests, and plasma concentrations of
30  reagent volumes when compared with standard hospital laboratory tests.
31                     In 1995, a 20% sample of hospital laboratories that responded to the initial ques
32 these recommended methods were being used in hospital laboratories was needed.
33 h Cryptosporidium oocysts were recognized by hospital laboratories were collected from 218 patients w
34 s and drug susceptibility data directly from hospital laboratories, whereas the CDC-sponsored system
35  be due to the culturing methods employed in hospital laboratories, which are unable to detect the un
36      The majority of testing is performed by hospital laboratories with an expected turnaround time o

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。